OptimizeRx (OPRX) Other Non-Current Liabilities (2010 - 2018)

OptimizeRx has reported Other Non-Current Liabilities for 9 years, with the latest figure at $1.3 million in Q2 2018.

• Quarterly Other Non-Current Liabilities fell 43.93% year-over-year to $1.3 million in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $1.3 million (down 43.93% YoY) and the FY2017 annual result came in at $1.3 million, down 43.93% from the prior year.
• Other Non-Current Liabilities held at $1.3 million in Q2 2018 per OPRX's latest filing, from $1.3 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $3.1 million in Q1 2014 and troughed at $1.3 million in Q4 2017.
• A 5-year average of $2.2 million and a median of $2.3 million in 2016 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2014 and 2015: Other Non-Current Liabilities plunged 88.24% in 2014, then gained 8.79% in 2015.
• Over 5 years, Other Non-Current Liabilities stood at $2.2 million in 2014, then climbed by 8.18% to $2.3 million in 2015, then declined by 1.51% to $2.3 million in 2016, then sank by 43.93% to $1.3 million in 2017, then changed by 0.0% to $1.3 million in 2018.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.3 million, $1.3 million, and $1.3 million for Q2 2018, Q1 2018, and Q4 2017 respectively.